Published on 19 Jun 2024 on Zacks · via Yahoo Finance
Enzo Biochem, Inc. ENZ delivered a loss per share of 4 cents from continuing operations in the third quarter of fiscal 2024, narrower than the year-ago quarter’s loss of 16 cents per share.
Revenues in Detail
Enzo Biochem’s Life Sciences Products reporting unit operates in one reportable segment, Products.